Agency As the Gavi 2024 African Vaccine Manufacturing Accelerator approaches, the Africa Centres for Disease Control and Prevention and the African Union have pledged their full support for the event. In a statement on Sunday, the African CDC said the AVMA inauguration, billed to be held on June 20 in Paris, France, will provide financial incentives to help vaccine manufacturers in Africa scale up production and become sustainable on a long-term basis. It said the Africa CDC recognised Gavi as a pivotal partner for health security and collective resilience to vaccine-preventable diseases across the continent.
According to the statement, Gavi has invested US$11.9 billion from 2000 to 2022 to enhance access to life-saving vaccines in Africa, preventing 11.1 million future deaths in the continent.
Gavi is expected to unveil a groundbreaking US$1 billion commitment over ten years through a new AVMA initiative aimed at bolstering African health security and sovereignty. The statement partly read, “This week, the Gavi board approved a 5-year new alliance strategy 2026-2030 which will be focusing on accelerating vaccine coverage, introducing new vaccines, strengthening health systems for equity, and supporting global health security and regional vaccine manufacturing. “As a public-private partnership, Gavi is funded through replenishment events hosted by donor governments to mobilize support from governments, philanthropies, the private sector, various institutions, civil societ.
